Key facts
- This page summarizes Lisa G. Wolf's Form 4 filing for Valion Bio, Inc. (VBIO).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Jun 2026, 16:30.
Lisa G. Wolf - 18 Jun 2026 Form 4 Insider Report for Valion Bio, Inc. (VBIO)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- VBIO
- Reported as of
- 18 Jun 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 18 Jun 2026, 16:30:27 UTC
- Prior SEC filing
- 19 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Lisa Wolf
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lisa G. Wolf filed Form 4 for Valion Bio, Inc. (VBIO) on 18 Jun 2026.
Change
- Previous filing in this sequence was filed on 19 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001861556
Primary reporting owner
Wolf Lisa G
- Relationship
- Chief Financial Officer
- Address
- 1305 E. HOUSTON ST., BLDG 1, STE. 311, SAN ANTONIO
- Signature
- /s/ Lisa Wolf
- Signature date
- 18 Jun 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
VBIO
transaction
Common Stock
Options Exercise
- Transaction value
- Shares
- +92
- Change %
- +17%
- Price
- Shares after
- 618
- Date
- 18 Jun 2026
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
VBIO
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- Shares
- -92
- Change %
- -14%
- Price
- $0.000000*
- Shares after
- 551
- Date
- 18 Jun 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 92
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Each Restricted Stock Unit is convertible into one share of Common Stock.
Footnote F2
Fifty percent (50%) of the Restricted Stock Units vested upon the one (1) year anniversary of the date of grant, December 18, 2024 (the "Vesting Commencement Date"), and the balance of the Restricted Stock Units will be vested in a series of eight (8) successive equal quarterly installments measured from the first anniversary of the Vesting Commencement Date such that one hundred percent (100%) of the Restricted Stock Units shall have vested on the third anniversary of the Vesting Commencement Date.